Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2022-11-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
$171.1m
reported value
33positions
93.3%in top 10
—no comparable previous quarter
Holdings, Q3 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $136.2m79.57% | — |
| ALDEYRA THERAPEUTICS INC ALDX | $10.0m5.86% | — |
| ENTERA BIO LTD ENTX | $2.6m1.51% | — |
| ALTIMMUNE INC ALT | $2.2m1.30% | — |
| Anavex Life Sciences Corp COM NEW | $2.2m1.27% | — |
| Orgenesis, Inc. COM | $1.9m1.09% | — |
| CVS HEALTH CORP CVS | $1.4m0.81% | — |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.2m0.70% | — |
| THERMO FISHER SCIENTIFIC INC TMO | $1.1m0.62% | — |
| APPLIED THERAPEUTICS INC APLT | $1.0m0.59% | — |
| ALTRIA GROUP INC MO | $917.0k0.54% | — |
| VISA INC V | $862.0k0.50% | — |
| BLACKSTONE GROUP L P BX | $838.0k0.49% | — |
| CORBUS PHARMACEUTICALS HLDGS CRBP | $833.0k0.49% | — |
| CORNING INC GLW | $773.0k0.45% | — |
| AGNICO EAGLE MINES LTD AEM | $650.0k0.38% | — |
| MAG SILVER CORP MAG | $599.0k0.35% | — |
| EIGER BIOPHARMACEUTICALS INC CLDN | $586.0k0.34% | — |
| FRANCO NEV CORP FNV | $585.0k0.34% | — |
| MAVERIX METALS INC COM NEW | $553.0k0.32% | — |
| SILVERCREST METALS INC SIL | $553.0k0.32% | — |
| WHEATON PRECIOUS METALS CORP WPM | $534.0k0.31% | — |
| OSISKO GOLD ROYALTIES LTD COM | $529.0k0.31% | — |
| SEABRIDGE GOLD INC COM | $487.0k0.28% | — |
| PAN AMERN SILVER CORP PAAS | $468.0k0.27% | — |
| EQUINOX GOLD CORP EQX | $361.0k0.21% | — |
| MIRATI THERAPEUTICS INC MRTX | $349.0k0.20% | — |
| ABEONA THERAPEUTICS INC COM | $269.0k0.16% | — |
| BIOXCEL THERAPEUTICS INC COM | $236.0k0.14% | — |
| CONTEXT THERAPEUTICS INC CNTX | $155.0k0.09% | — |
| ANNOVIS BIO INC ANVS | $147.0k0.09% | — |
| ORAMED PHARMACEUTICALS INC ORMP | $130.0k0.08% | — |
| SOLIGENIX INC COM | $15.0k0.01% | — |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |